Zoetis | ZTS

Stock Price
153.32
Daily Change
0.12 0.08%
Monthly
4.66%
Yearly
-19.13%
Q3 Forecast
152.05

Peers Price Chg Day Year Date
AbbVie 212.56 -0.44 -0.21% 9.95% Sep/05
Align Technology 139.12 4.42 3.28% -37.08% Sep/05
Bayer 28.16 -0.42 -1.47% -1.83% Sep/06
Bristol-Myers Squibb 47.14 0.45 0.96% -3.28% Sep/05
Charles River Laboratories 163.99 1.68 1.04% -12.63% Sep/05
Quest Diagnostics 183.49 3.38 1.88% 20.12% Sep/05
Henry Schein 69.43 1.65 2.43% 0.90% Sep/05
Idexx Laboratories 642.99 2.55 0.40% 36.13% Sep/05
Illumina 98.93 1.25 1.28% -20.47% Sep/05
IQVIA Holdings 187.68 3.60 1.96% -22.83% Sep/05
J&J 178.43 -0.33 -0.18% 8.51% Sep/05
Laboratory Of America 278.67 3.44 1.25% 24.30% Sep/05
Eli Lilly 727.21 -15.70 -2.11% -19.48% Sep/05
Merck 84.71 0.66 0.79% -28.14% Sep/05
Neogen 5.75 0.01 0.17% -62.71% Sep/05
Pacira 26.45 -0.28 -1.05% 90.97% Sep/05
Pfizer 24.88 0.34 1.39% -12.95% Sep/05
Perrigo 23.49 -0.25 -1.05% -19.14% Sep/02
Sanofi 79.50 0.54 0.68% -24.83% Sep/06
Sanofi 46.50 1.18 2.60% -19.47% Sep/05
Dentsply International 14.62 0.29 2.02% -42.75% Sep/05
Zoetis 153.32 0.12 0.08% -19.13% Sep/05

Indexes Price Day Year Date
US500 6481 -20.59 -0.32% 19.84% Sep/05

Zoetis traded at $153.32 this Friday September 5th, increasing $0.12 or 0.08 percent since the previous trading session. Looking back, over the last four weeks, Zoetis gained 4.66 percent. Over the last 12 months, its price fell by 19.13 percent. Looking ahead, we forecast Zoetis to be priced at 152.05 by the end of this quarter and at 148.29 in one year, according to Trading Economics global macro models projections and analysts expectations.

Zoetis Inc. is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products, biodevices, genetic tests and precision livestock farming technology. The Company has a business, commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, swine, poultry, fish and sheep (collectively, livestock); and within product categories such as vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. The Company's segments include the United States and International. Within each of these operating segments, it offers a product portfolio for both livestock and companion animal customers.